Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07328854
What this trial is testing

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ming-Yuan Chen 346
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07397442
What this trial is testing

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III
Beijing Friendship Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00858806
What this trial is testing

Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 78
Large-scale testing (Phase 3)UnknownNCT02937012
What this trial is testing

Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

Who this might be right for
Primary Biliary Cirrhosis
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 34
Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Not applicableLooking for participantsNCT05184582
What this trial is testing

Physical Exercise During Preoperative Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Karolinska Institutet 712
Not applicableUnknownNCT04724785
What this trial is testing

Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients

Who this might be right for
Sustained Virologic ResponseHepatitis B, Chronic
The Second Affiliated Hospital of Chongqing Medical University 10,000
Not applicableStudy completedNCT00896129
What this trial is testing

Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 448
Testing effectiveness (Phase 2)Ended earlyNCT00415857
What this trial is testing

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Not applicableNot Yet RecruitingNCT07596472
What this trial is testing

Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer

Who this might be right for
Breast CancerAxillary Lymph Node MetastasisNeoadjuvant Chemotherapy+1 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150
Not applicableActive Not RecruitingNCT03289195
What this trial is testing

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 31
Large-scale testing (Phase 3)Looking for participantsNCT04314219
What this trial is testing

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) in Complete RemissionAcute Myeloid Leukemia (AML) in Remission
King Faisal Specialist Hospital & Research Center 264
Testing effectiveness (Phase 2)Looking for participantsNCT04677816
What this trial is testing

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Who this might be right for
Triple Negative Breast CancerVitamin D DeficiencyInvasive Breast Cancer
Wake Forest University Health Sciences 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06903871
What this trial is testing

Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)

Who this might be right for
Esophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III
Hebei Medical University Fourth Hospital 190
Not applicableUnknownNCT01612247
What this trial is testing

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
University of Vermont 13
Testing effectiveness (Phase 2)Study completedNCT01349478
What this trial is testing

The Effects of Passive Gait Training in Complete Motor Spinal Cord Injury (SCI)

Who this might be right for
Motor Complete Spinal Cord Injury
Dr. Gabriel Zeilig 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811375
What this trial is testing

Perioperative Adebrelimab for Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
Anhui Provincial Hospital 35
Not applicableStudy completedNCT03540654
What this trial is testing

Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach

Who this might be right for
Hematologic DiseasesChronic Myeloid Leukemia
University Hospital, Bordeaux 355
Next Page